Anakinra for children with acute myocarditis in the ICU
Part of Heart & circulation clinical trials.
This trial tests whether a medicine called anakinra can help children with acute myocarditis (heart inflammation) in the ICU. It aims to see if the drug reduces heart damage and improves recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 3 months and 18 years old.
- They must be in the intensive care unit (ICU) with acute myocarditis (heart inflammation) and a weakened heart.
- Your child must weigh at least 5 kg (about 11 pounds).
- They cannot have had a heart condition or heart surgery before this illness.
- They cannot have a serious infection, a weak immune system, or a history of cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two treatments—anakinra and IVIG—for children with Kawasaki disease who still have fever after their first standard IVIG treatment. It aims to find which option works better and is safer for “IVIG non-responders” who may be at risk for heart complications.
This trial tests if taking anakinra (a targeted medicine) only when you have a painful FMF attack can help, instead of taking it every day. It is for people with Familial Mediterranean Fever (FMF) whose attacks continue despite taking colchicine, and who do not want daily injections.
This trial tests whether anakinra is at least as effective as standard treatment for children with Kawasaki disease. It aims to prevent heart complications caused by inflammation in the blood vessels.
This trial tests different doses and ways of giving a medicine called anakinra to preterm babies. It aims to find the safest and most effective dose to help reduce inflammation.
This study tests whether a medicine called anakinra can “turn down” harmful inflammation in children with severe illness from sepsis. It aims to improve organ function when multiple organs are starting to fail.
This study tests whether a medication called anakinra can help treat asthma attacks in people who already take daily asthma controller medications. Anakinra works by reducing inflammation in the airways, and researchers want to see if it can help people recover faster from moderate asthma flare-ups.
Hear when a new PEDIATRIC ACUTE MYOCARDITIS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.